Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.698,62
0,32%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Incyte Corporation (INCY) Incyte Corporation (INCY) Notizie

Incyte Corporation

INCY
57,79
0,49 (0,86%)
01 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
30/5/202422:05BWIncyte Completes Acquisition of Escient Pharmaceuticals
30/5/202421:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/5/202419:15BWIncyte Expands Presence in Delaware through Acquisition of..
21/5/202414:00BWIncyte to Present at Upcoming Investor Conference
16/5/202403:45BWIncyte präsentiert Daten aus seinem Onkologie-Portfolio beim..
15/5/202417:44BWIncyte présentera les données de son portefeuille..
15/5/202417:10EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
14/5/202423:00BWIncyte to Highlight Data From its Oncology Portfolio at the..
14/5/202415:05IHMARKETNEWSProducer Price Inflation Data May Weigh On Wall Street
14/5/202400:06EDGAR2Form SC 13D/A - General statement of acquisition of..
13/5/202422:34IHMARKETNEWSDow Snaps Eight-Day Winning Streak After Lackluster Session
13/5/202417:19EDGAR2Form SC TO-I - Tender offer statement by Issuer
13/5/202413:19EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/5/202413:18EDGAR2Form 8-K - Current report
13/5/202413:00BWIncyte Announces Intention to Buy Back up to $2.0 Billion of..
10/5/202400:40EDGAR2Form SC 13D/A - General statement of acquisition of..
10/5/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/5/202414:00BWIncyte to Present at Upcoming Investor Conference
30/4/202413:00BWIncyte Reports 2024 First Quarter Financial Results and..
24/4/202400:11BWIncyte annonce l'acquisition d'Escient Pharmaceuticals et de..
24/4/202400:01BWIncyte gibt Übernahme von Escient Pharmaceuticals und dessen..
23/4/202413:00BWIncyte Announces Acquisition of Escient Pharmaceuticals and..
11/4/202414:00BWIncyte to Report First Quarter Financial Results
01/4/202414:30BWIncyte and CMS Announce Collaboration and License Agreement..
29/3/202421:30BWIncyte Reports Inducement Grant Under Nasdaq Listing Rule..
11/3/202413:57BWIncyte gibt neue Daten aus Phase-2-Studie zur Untersuchung..
11/3/202411:06BWIncyte présente de nouvelles données de l’étude de phase 2..
11/3/202410:53BWIncyte legt neue brandaktuelle Daten aus Phase-2-Studie zur..
10/3/202421:05BWIncyte Presents New Late-Breaking Data from Phase 2 Study..
04/3/202420:38BWDe nouvelles données dérivées du portefeuille dermatologique..
04/3/202420:02BWNeue Daten aus dem wachsenden Dermatologieportfolio von..
04/3/202414:00BWNew Data from Incyte’s Growing Dermatology Portfolio to be..
29/2/202416:19BWIncyte Launches The Unseen Journey to Elevate the Hidden..
29/2/202413:30GLOBEKnight Therapeutics Announces Launch of Minjuvi® in Brazil
28/2/202415:11BWIncyte annonce que la Food and Drug Administration des..
28/2/202413:15BWIncyte gibt bekannt, dass die US-Arzneimittelbehörde FDA..
27/2/202422:08BWIncyte Announces U.S. Food and Drug Administration Grants..
16/2/202422:04EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
16/2/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202418:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202414:00BWIncyte to Present at Upcoming Investor Conference
14/2/202418:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202423:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
13/2/202422:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
13/2/202413:03EDGAR2Form 8-K - Current report
13/2/202413:00BWIncyte Reports 2023 Fourth Quarter and Year-End Financial..
Apertura: 57,36 Min: 57,30 Max: 57,98
Chiusura: 57,30

La tua Cronologia

NASDAQ
INCY
Incyte
NYSE
FMC
FMC
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network